Equities

medmix AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

medmix AG

Actions
  • Price (CHF)11.81
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change--
  • Beta1.6949
Data delayed at least 15 minutes, as of Jan 27 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Tuesday, medmix AG (8KQ:BRN) closed at 11.81, 0.00% below its 52-week high of 11.81, set on Jan 27, 2026.
52-week range
Today
8.72Oct 06 202511.81Jan 27 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open11.81
High11.81
Low11.81
Bid11.52
Offer11.67
Previous close11.81
Average volume100.00
Shares outstanding41.26m
Free float24.48m
P/E (TTM)--
Market cap484.42m CHF
EPS (TTM)-0.1696
CHF
Annual div (ADY)0.50
CHF
Annual div yield (ADY)4.23%
Div ex-dateApr 25 2025
Div pay-dateApr 29 2025
Data delayed at least 15 minutes, as of Jan 27 2026.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.